Показано 0 из 0
Дата |
---|
03.05.2024 |
02.05.2024 |
01.05.2024 |
30.04.2024 |
29.04.2024 |
26.04.2024 |
25.04.2024 |
24.04.2024 |
23.04.2024 |
22.04.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
4.38
|
4.89
|
4.67
|
4.42
|
4.80
|
4.62
|
|
|
1 368 917.63
|
3 983.00
|
3.70
|
4.95
|
4.22
|
4.12
|
4.48
|
4.36
|
|
|
526 321.72
|
2 150.00
|
4.10
|
4.60
|
4.27
|
3.91
|
4.32
|
4.15
|
|
|
1 010 969.41
|
1 944.00
|
4.00
|
6.00
|
4.66
|
4.21
|
4.95
|
4.27
|
|
|
1 275 596.29
|
1 913.00
|
4.50
|
4.83
|
4.37
|
4.2935
|
4.85
|
4.64
|
|
|
1 308 127.33
|
2 797.00
|
4.25
|
4.46
|
3.68
|
3.68
|
4.85
|
4.41
|
|
|
3 990 291.13
|
7 244.00
|
3.66
|
3.80
|
3.51
|
3.36
|
3.7965
|
3.62
|
|
|
1 223 567.81
|
2 639.00
|
3.52
|
3.64
|
3.47
|
3.13
|
3.56
|
3.31
|
|
|
2 779 434.10
|
7 094.00
|
3.25
|
3.56
|
3.27
|
3.27
|
3.65
|
3.48
|
|
|
470 551.91
|
1 626.00
|
2.75
|
3.30
|
3.48
|
3.20
|
3.4931
|
3.31
|
|
|
332 801.01
|
1 427.00
|
Zura is a clinical-stage biotechnology company advancing immunology assets into Phase 2 development programs, including ZB-168 and torudokimab.